PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ovarian cancer patients with residual disease after surgery
Disease control OngoingThis study is testing whether the drug bevacizumab (Avastin) can help control ovarian, fallopian tube, or primary peritoneal cancer that was discovered during a second surgery after initial treatment. The research involves 35 participants who have completed standard chemotherapy …
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Pronged attack on recurring ovarian cancer
Disease control OngoingThis study is testing a two-part treatment for ovarian cancer that has come back after initial chemotherapy. It combines a standard chemotherapy drug with a newer, targeted drug designed to attack cancer cells with a specific marker. After the combination phase, patients continue…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug combo tested in fight against tough ovarian cancer
Disease control OngoingThis small, early-stage study is testing if adding a bone drug (zoledronic acid) to standard chemotherapy (paclitaxel and bevacizumab) helps control recurrent ovarian cancer that has stopped responding to platinum drugs. It will involve about 14 women to see if the three-drug com…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Targeted drug trial for Tough-to-Treat ovarian cancer withdrawn before start
Disease control TerminatedThis study aimed to test a new targeted drug called BAT8006 for women with advanced ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. The two-part trial planned to first find a safe and effective dose, then …
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New weapon tested in battle against advanced ovarian cancer
Disease control OngoingThis study is testing whether adding a new experimental drug called IMNN-001 to standard chemotherapy before surgery can better control advanced ovarian, fallopian tube, or primary peritoneal cancer. The drug is designed to stimulate the immune system and is delivered directly in…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Imunon • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC